4980
H. Shimomura et al. / Bioorg. Med. Chem. Lett. 17 (2007) 4977–4981
Table 2. Inhibitory activity of optically pure 70-hydroxy-ABA and its
analogues against recombinant CYP707A3
Acknowledgment
Inhibitiona (%)
·10
We thank Toray Industries Inc., Tokyo, Japan, for the
gift of (+)-ABA.
Compound
·1
(+)-70-Hydroxy-ABA
(+)-70-Oxo-ABA
(+)-10-Deoxy-70-hydroxy-ABA
(+)-70-Methyl-ABA
(+)-10-Deoxy-ABA
0
0
15
0
3
63
24
83c
73c
1
4
Supplementary data
b
—
—
1
Synthetic procedure of new compounds and their H
and 13C NMR, high resolution MS, specific rotation,
and circular dichroism data are given. Supplementary
data associated with this article can be found, in the on-
a Inhibition ratio in the 80-hydroxylation for ABA (5 lM). The con-
centrations of compounds are 5 lM (·1) and 50 lM (·10). The
inhibition ratios reported in this paper are the averages and standard
deviations of three sets of experiments.
b Not measured.
c Ref. 10.
References and notes
The inhibitory activity of the optically pure compounds
against recombinant CYP707A3 is summarized in Table
2.17 The activity was evaluated based on the decrease of
the enzyme products, 80-hydroxy-ABA and phaseic
acid, caused by addition of a test compound at a concen-
tration equal to or 10 times higher than the substrate
(+)-ABA. (+)-70-Hydroxy-ABA had no inhibitory
effect on the enzyme reaction at the tested concentra-
tions. (+)-10-Deoxy-70-hydroxy-ABA was also a very
weak inhibitor, although it was a little more potent than
(+)-70-hydroxy-ABA. Only (+)-70-oxo-ABA exhibited
a significant activity, which was a little bit weaker than
that of (+)-70-methyl-ABA and (+)-10-deoxy-ABA.
All the (ꢀ)-isomers exhibited no significant inhibitory
activity (data not shown).
1. Kushiro, T.; Okamoto, M.; Nakabayashi, K.; Yamagishi,
K.; Kitamura, S.; Asami, T.; Hirai, N.; Koshiba, T.;
Kamiya, Y.; Nambara, E. EMBO J. 2004, 23, 1647.
2. Saito, S.; Hirai, N.; Matsumoto, C.; Ohigashi, H.; Ohta,
D.; Sakata, K.; Mizutani, M. Plant Physiol. 2004, 134,
1439.
3. Hirai, N. In Comprehensive Natural Products Chemistry;
Mori, K., Ed.; Elsevier: Amsterdam, 1999; Vol. 8, pp
72–91.
4. Abscisic Acid; Davies, W. J., Jones, H. G., Eds.; BIOS
Scientific Publishers: Oxford, 1991.
5. Zeevaart, J. A. D.; Creelman, R. A. Annu. Rev. Plant
Physiol. Plant Mol. Biol. 1998, 39, 439.
6. Abscisic Acid; Addicott, F. T., Ed.; Praeger: New York,
1983.
7. Walker-Simmons, M. K.; Holappa, L. D.; Abrams, G. D.;
Abrams, S. R. Physiol. Plant. 1997, 100, 474, and
references cited therein.
8. Araki, Y.; Miyawaki, A.; Miyashita, T.; Mizutani, M.;
Hirai, N.; Todoroki, Y. Bioorg. Med. Chem. Lett. 2006,
16, 3302.
9. Ueno, K.; Yoneyama, H.; Saito, S.; Mizutani, M.; Sakata,
K.; Hirai, N.; Todoroki, Y. Bioorg. Med. Chem. Lett.
2005, 15, 5226, We named the lead compound in this ref.
as AHI1.
10. Ueno, K.; Araki, Y.; Hirai, N.; Saito, S.; Mizutani, M.;
Sakata, K.; Todoroki, Y. Bioorg. Med. Chem. 2005, 13,
3359.
The catalytic cycle of a cytochrome P450 enzyme is trig-
gered as the substrate enters into the active site and dis-
places the axial water molecule. After the hydroxylation
reaction, the hydroxylated substrate causes the entrance
of bulk water molecules into the substrate-binding pock-
et which results in the release of the product from the
enzyme.18 This suggests that a substrate affinity for the
pocket decreases as its hydrophilicity is increased. In
fact, (+)-70-hydroxy-ABA, which is the most hydrophilic
compound, was the most inactive in (+)-isomers. How-
ever, (+)-10-deoxy-70-hydroxy-ABA was little active in
spite of its more hydrophobic character compared to
(+)-ABA, whereas (+)-70-oxo-ABA was more potent
than (+)-10-deoxy-70-hydroxy-ABA in spite of its less
hydrophobic character. Steric bulkiness of the 70-substit-
uents is not significant in this case, because introduction
of a methyl group at C-70 has little effect on binding to
the active site.10 Likewise, the presence or absence of the
oxygen at C-10 does not affect the inhibitory potency.10
Thus the local polarity at C-70, neither the steric bulki-
ness nor overall molecular hydrophilicity, would be the
major reason why (+)-70-hydroxy-ABA is not a potent
inhibitor. The potency of (+)-70-oxo-ABA suggests that
the hydrogen rather than the oxygen of the 70-hydroxyl
group causes some disadvantageous interaction with the
substrate-binding cavity of the enzyme, or interferes
with the approach of the compound to the cavity. The
present findings will be useful for designing a specific
inhibitor of CYP707A as a structural analogue of
ABA, in addition to discussing the substrate binding
mechanism of CYP707A.
11. Nelson, A. K.; Shaw, A. C.; Abrams, S. R. Tetrahedron
1991, 47, 3259.
12. The synthetic procedure and optical resolution of 70-
hydroxy-ABA, 10-deoxy-70-hydroxy-ABA, and 70-oxo-
ABA can be found in the supplementary data.
10-Deoxy-70-hydroxy-ABA and 70-oxo-ABA are new
ABA analogues. 10-Deoxy-70-hydroxy-ABA: 1H NMR
(500 MHz, CD3OD): d 1.01 (3H, s, H3-90), 1.06 (3H, s,
H3-80), 2.02 (3H, s, H3-6), 2.13 (1H, d, J = 16.8 Hz,
H-50), 2.56 (1H, d, J = 16.8 Hz, H-50), 2.83 (1H, d,
J = 9.6 Hz, H-10), 4.14 (2H, m, H2-70), 5.72 (1H, s, H-2),
6.11 (1H, dd, J = 15.8 and 9.6 Hz, H-5), 6.18 (1H, s,
H-30), 7.66 (1H, d, J = 15.8 Hz, H-4); HREIMS: [M]+ at
m/z 264.1360 (C15H20O4 requires 264.1362). 70-Oxo-
ABA: 1H NMR (270 MHz, CDCl3): d 1.08 (3H, s,
H3-90), 1.14 (3H, s, H3-80), 2.04 (3H, d, J = 1.0 Hz,
H3-6), 2.32 (1H, d, J = 16.8 Hz, H-50), 2.52 (1H, d,
J = 16.8 Hz, H-50), 4.36 (1H, s, HO-10), 5.76 (1H, s, H-
2), 6.25 (1H, d, J = 16.5 Hz, H-5), 6.69 (1H, s, H-30),
7.56 (1H, d, J = 16.5 Hz, H-4), 9.75 (1H, s, H-70);
HREIMS: [M]+ at m/z 278.1161 (C15H18O5 requires
278.1154).